Broker-Dealers on SEC Form D for WILMINGTON CAPITAL SECURITIES, LLC

Search by Recipient Name or Primary Issuer:

Displaying 10 out of 37 results

Recipient	CRD	Primary Issuer	CIK	Filing Date	Form Type	Total Offering Amount	Total Amount Sold
WILMINGTON CAPITAL SECURITIES, LLC	133839	GPB Holdings II, LP	1640265	05/16/2018	D/A	Indefinite	$645,813,889
WILMINGTON CAPITAL SECURITIES, LLC	133839	TEI Diversified Income & Opportunity Fund IV LLC	1728129	01/17/2020	D/A	$150,000,000	$128,639,555
WILMINGTON CAPITAL SECURITIES, LLC	133839	TEI Diversified Income & Opportunity Fund IV LLC	1728129	01/27/2020	D/A	$150,000,000	$128,639,555
WILMINGTON CAPITAL SECURITIES, LLC	133839	TEI Diversified Income & Opportunity Fund III, LLC	1671607	03/16/2018	D/A	$67,347,213	$67,347,213
WILMINGTON CAPITAL SECURITIES, LLC	133839	Coya Therapeutics, Inc.	1835022	05/20/2022	D	$20,000,000	$10,443,970
WILMINGTON CAPITAL SECURITIES, LLC	133839	Arca Digital Assets Fund, LP	1750134	10/06/2020	D/A	Indefinite	$9,141,330
WILMINGTON CAPITAL SECURITIES, LLC	133839	Radiance Therapeutics, Inc.	1742457	06/29/2023	D/A	$10,500,000	$8,989,186
WILMINGTON CAPITAL SECURITIES, LLC	133839	PF MANAGEMENT SERVICES, LLC	1593211	10/23/2015	D	$7,311,862	$7,311,862
WILMINGTON CAPITAL SECURITIES, LLC	133839	Adams Arms, LLC	1554366	09/12/2012	D	$7,047,206	$7,047,206
WILMINGTON CAPITAL SECURITIES, LLC	133839	LIBERATOR MEDICAL HOLDINGS, INC.	17485	03/11/2010	D	$7,000,000	$7,000,000